Free Trial

UnitedHealth CEO steps down for “personal reasons”

Key Points

  • Andrew Witty resigned as CEO of UnitedHealth Group effective immediately for personal reasons, and former CEO and board chairman Stephen Hemsley will reassume the role.
  • UnitedHealth has suspended its financial guidance for the rest of the year due to higher-than-expected costs in its Medicare Advantage program, while forecasting a return to growth in 2026.
  • The company’s stock suffered its steepest one-day decline in nearly 30 years with a 20% drop followed by an additional 11% fall in premarket trading after Witty’s departure.
  • In a New York Times op-ed, Witty acknowledged growing public dissatisfaction with the American healthcare system and admitted UnitedHealthcare bears partial blame for a lack of openness.
  • Five stocks to consider instead of New York Times.

On Tuesday, UnitedHealth Group announced that Andrew Witty, its CEO, had resigned from his position. The resignation happened immediately due to personal reasons. Stephen Hemsley, the former CEO and chairman of the company’s board, will take over as CEO once more.

Witty, who has been in charge of the healthcare conglomerate for the last four years, will continue to work for the company in a limited role as Hemsley’s senior adviser. The organization is under significant internal and external pressure with Witty departing.

UnitedHealth CEO steps down

Hemsley was extremely grateful for Witty’s leadership. Hemsley said Witty took on “some of the most challenging times any company has ever faced.” In a formal statement, Hemsley wished Witty and his family well and praised him for his leadership and kindness.

During Witty’s tenure, previous CEO Brian Thompson was shot dead outside a New York hotel last year. Witty was instrumental in steering UnitedHealth Group through the fallout as its CEO. The incident led to widespread criticism of the insurance and healthcare industries.

In a New York Times op-ed, Witty admitted that insurance decisions are frequently misinterpreted and acknowledged the public’s mounting dissatisfaction with the American healthcare system. He acknowledged that UnitedHealthcare is partially to blame for this lack of openness while defending the company.

UnitedHealth Group has suspended its financial guidance for the remainder of the year in addition to the leadership change. Although it predicted a return to growth in 2026, the company blamed the pause on higher-than-expected costs in its Medicare Advantage program.

Concerns about the company’s trajectory were also expressed in Witty’s recent comments during an earnings call. Prior to a historic 20% decline in stock value—the company’s steepest single-day decline in almost 30 years—he made the rare and candid admission that UnitedHealth’s recent performance was “unusual and unacceptable.”

UnitedHealth’s stock continued to decline after Witty’s resignation was announced, dropping almost 11% in premarket trading on Tuesday.

Featured Image Credit: RDNE Stock Project; Pexels: Thank You!

The post UnitedHealth CEO steps down for “personal reasons” appeared first on Due.

Should You Invest $1,000 in New York Times Right Now?

Before you consider New York Times, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and New York Times wasn't on the list.

While New York Times currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report
Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
New York Times (NYT)
3.2085 of 5 stars
$54.85+0.1%1.31%30.81Hold$56.00
UnitedHealth Group (UNH)
4.997 of 5 stars
$296.45-2.2%2.83%19.13Moderate Buy$441.87
Compare These Stocks  Add These Stocks to My Watchlist 

Featured Articles and Offers

Recent Videos

The Hottest AI Stock You Haven’t Bought Yet
This $13 Trillion Energy Breakthrough Will Make Millionaires
Magnificent 7 Stocks Shift Toward Stability and Selective Growth

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines